Cunjin Wu

1.3k total citations · 1 hit paper
17 papers, 763 citations indexed

About

Cunjin Wu is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Cunjin Wu has authored 17 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Cunjin Wu's work include Influenza Virus Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Cunjin Wu is often cited by papers focused on Influenza Virus Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Cunjin Wu collaborates with scholars based in China, United States and Canada. Cunjin Wu's co-authors include Sean X. Leng, Huifen Li, Yiyin Chen, Sabra L. Klein, Taisheng Li, Brian T. Garibaldi, Graham Pawelec, Joseph B. Margolick, Xin Li and Lin Wang and has published in prestigious journals such as Hypertension, BMC Medicine and Ageing Research Reviews.

In The Last Decade

Cunjin Wu

16 papers receiving 745 citations

Hit Papers

Aging in COVID-19: Vulnerability, immunity and intervention 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cunjin Wu China 7 332 181 127 100 90 17 763
Charles Raine United Kingdom 8 548 1.7× 213 1.2× 88 0.7× 124 1.2× 183 2.0× 17 1.0k
Maeve S. McNamara United States 1 321 1.0× 174 1.0× 58 0.5× 119 1.2× 105 1.2× 2 683
Zeeshan Ahmed Pakistan 8 403 1.2× 199 1.1× 94 0.7× 103 1.0× 132 1.5× 38 856
Pranav Ish India 16 437 1.3× 177 1.0× 60 0.5× 106 1.1× 88 1.0× 121 813
Huiling Liang China 12 592 1.8× 297 1.6× 147 1.2× 91 0.9× 219 2.4× 20 1.2k
Risha Patidar Nigeria 5 600 1.8× 271 1.5× 95 0.7× 175 1.8× 188 2.1× 10 1.1k
Cecilia Acuti Martellucci Italy 17 384 1.2× 106 0.6× 120 0.9× 69 0.7× 80 0.9× 50 801
Bhupinder Natt United States 11 251 0.8× 157 0.9× 48 0.4× 90 0.9× 68 0.8× 25 759
Kokab Younis Canada 2 568 1.7× 258 1.4× 85 0.7× 158 1.6× 184 2.0× 3 954
Priyank Desai Nigeria 7 610 1.8× 273 1.5× 98 0.8× 171 1.7× 190 2.1× 11 1.1k

Countries citing papers authored by Cunjin Wu

Since Specialization
Citations

This map shows the geographic impact of Cunjin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunjin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunjin Wu more than expected).

Fields of papers citing papers by Cunjin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunjin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunjin Wu. The network helps show where Cunjin Wu may publish in the future.

Co-authorship network of co-authors of Cunjin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Cunjin Wu. A scholar is included among the top collaborators of Cunjin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunjin Wu. Cunjin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Yang, Wuping, et al.. (2025). FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression. Cell Death Discovery. 11(1). 115–115. 2 indexed citations
3.
Chen, Yan, Cunjin Wu, Huifen Li, et al.. (2023). Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza. Influenza and Other Respiratory Viruses. 17(3). e13112–e13112. 5 indexed citations
4.
Chen, Yú, Jian Li, ‪Shuyuan Zhang, et al.. (2022). Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: A longitudinal study. Clinical Genetics. 101(4). 411–420. 5 indexed citations
5.
Xiao, Xiao, Rui Li, Cunjin Wu, et al.. (2022). A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension. BMC Medicine. 20(1). 463–463. 3 indexed citations
7.
Shapiro, Janna R., Huifen Li, Rosemary Morgan, et al.. (2021). Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. npj Vaccines. 6(1). 147–147. 23 indexed citations
8.
Zhang, ‪Shuyuan, Liyuan Tao, Cunjin Wu, et al.. (2021). Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China. Chinese Medical Journal. 134(3). 292–301. 4 indexed citations
9.
Chen, Yiyin, Sabra L. Klein, Brian T. Garibaldi, et al.. (2020). Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Research Reviews. 65. 101205–101205. 608 indexed citations breakdown →
10.
Cheng, Yangyang, Xinxi Cao, Zhi Cao, et al.. (2020). Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Research Reviews. 62. 101124–101124. 29 indexed citations
11.
Zhang, ‪Shuyuan, Rongxia Li, Yu Chen, et al.. (2020). Longitudinal Association of Telomere Attrition with the Effects of Antihypertensive Treatment and Blood Pressure Lowering. Aging and Disease. 11(3). 494–494. 11 indexed citations
12.
He, Mingli, Bing Cui, Cunjin Wu, et al.. (2018). Blood pressures immediately following ischemic strokes are associated with cerebral perfusion and neurologic function. Journal of Clinical Hypertension. 20(6). 1008–1015. 6 indexed citations
13.
Wu, Cunjin, et al.. (2018). Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study. Clinical and Experimental Hypertension. 41(8). 753–758. 6 indexed citations
14.
Su, Nan, Jiangtao Lin, Kai Yin, et al.. (2016). [A cross-section study of severe asthma in eight provinces of China].. PubMed. 55(12). 917–921. 8 indexed citations
16.
Xia, Xiaoshuang, et al.. (2014). Supplementation of folic acid and vitamin B12 reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. Journal of Clinical Neuroscience. 21(9). 1586–1590. 27 indexed citations
17.
Wu, Cunjin, et al.. (2012). [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].. PubMed. 40(12). 1003–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026